Understanding how visual impairments contribute to Alzheimer's disease

Disruption of sensory pathways in dementia pathogenesis

NIH-funded research Northeast Ohio Medical University · NIH-10888472

This study is looking at how problems with vision might be linked to the early signs of Alzheimer's disease, especially by checking how certain proteins in the eye could affect how we see and think, with the hope of finding new ways to help people with dementia.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionNortheast Ohio Medical University NIH-funded
Lab location1 site (Rootstown, United States)
Project IDNIH-10888472 on NIH RePORTER

What this research studies

This research investigates the connection between visual sensory impairments and the onset of Alzheimer's disease. It aims to identify how the accumulation of amyloid and tau proteins in the eye affects the primary visual pathway from the retina to the brain. By studying these changes, the research seeks to uncover new mechanisms that could lead to early interventions for dementia. The approach includes using experimental models to observe the effects of these proteins on neuronal activity in the visual cortex.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing early visual impairments or those at risk for Alzheimer's disease.

Not a fit: Patients with advanced Alzheimer's disease or those without any visual impairments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for early detection and prevention of Alzheimer's disease.

How similar studies have performed: Preliminary research has shown promising results regarding the role of visual dysfunction in Alzheimer's disease, indicating that this approach has potential for significant findings.

Where this research is happening

Rootstown, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.